Cancer

Behind the FDA’s AI Push: A Growing Class of Public Healthcare Innovators

USA News Group News CommentaryIssued on behalf of Avant Technologies Inc. VANCOUVER, BC, May 13, 2025 /PRNewswire/ -- USA News…

8 months ago

American College of Lifestyle Medicine announces integration of first set of lifestyle behavior assessment tools into Epic electronic health records

The introduction of standardized measures for assessing lifestyle change opportunities in Epic, a national leader in electronic health records software,…

8 months ago

Illumina DRAGEN v4.4 powers clinical oncology research and multiomic applications

Building on reputation for unparalleled performance, latest software delivers even greater accuracy, with 30% improvement in structural variant calling New…

8 months ago

General Oncology to Participate in Three Upcoming Conferences

BOSTON, May 13, 2025 (GLOBE NEWSWIRE) -- General Oncology, Inc., a clinical-stage biopharmaceutical company dedicated to pioneering first-in-class treatments for…

8 months ago

Shineco’s Subsidiary InfiniClone Partners with Total World Marketing for Entry into the Southeast Asian Healthcare Market

BEIJING, May 13, 2025 (GLOBE NEWSWIRE) -- Shineco, Inc. ("Shineco" or the "Company"; NASDAQ: SISI), a provider of innovative diagnostic…

8 months ago

Complement 1 Secures $16M Seed Round to Scale Clinically Validated Cancer Lifestyle Modification Platform

Evidence-based lifestyle modification platform for oncology achieves 90%+ adherence with new dedicated CoActive Coach model, significantly improving cancer-related health outcomes.NEW…

8 months ago

HCW Biologics Announces Positive Results of Studies of Proprietary Compound, HCW9206 and Availability for Commercialization

Addresses key challenges for CAR-T therapies Potential to significantly reduce costs and improve clinical efficacy of engineered effector T cells…

8 months ago

CytoDyn Announces Data Suggesting Novel Mechanism of Action of Leronlimab for the Treatment of Solid Tumors

Survival observations in mTNBC patients correlated with increased PD-L1 expression Preliminary evidence suggests leronlimab has potential to turn “cold” tumors…

8 months ago

Affimed Announces Filing for the Opening of Insolvency Proceedings

MANNHEIM, Germany, May 13, 2025 (GLOBE NEWSWIRE) -- Affimed N.V. (Nasdaq: AFMD), a clinical-stage immuno-oncology company committed to giving patients…

8 months ago

VivoSim’s NAMKind™ Intestine Wins Blue Ribbon Award at Digestive Disease Week Conference

SAN DIEGO, May 13, 2025 (GLOBE NEWSWIRE) -- VivoSim Labs, Inc. (Nasdaq: VIVS) (the “Company” or “VivoSim”) announced today that…

8 months ago